Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TestoSup: Testosterone Supplementation in Palliative Care
NCT07143279Phase 1Recruiting
- Sponsor
- Institut Jules Bordet
- Start
- Feb 2026
- Primary completion
- Nov 2026
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Sustanon 250 in Hypogonadism, sponsored by Institut Jules Bordet. Primary endpoints: Activities of Daily Living Questionnaire and Edmonton Symptom Assessment Scale. Started Feb 2026; status: recruiting.
02
Drugs
Sustanon 250
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT07143279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07143279.